Fusion Clinical Research

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Obesity3 trials
• High blood pressure1 trial
• Obstructive sleep apnoea1 trial
• Osteoarthritis1 trial
• Type 2 diabetes1 trial

Phase

• Phase 34 trials

Status

• Completed3 trials
• Recruiting1 trial

Lead sponsor

• Eli Lilly and Company2 trials
• Amgen1 trial
• Mineralys Therapeutics Inc.1 trial

Running trials

• Recruiting

  Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

  NCT07684235· Phase 3· Amgen· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity1 recruiting

Closed trials

• Completed

  Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension

  NCT06153693· Phase 3· Mineralys Therapeutics Inc.· Source

• Completed

  A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight

  NCT05929066· Phase 3· Eli Lilly and Company· Source

• Completed

  A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease

  NCT05882045· Phase 3· Eli Lilly and Company· Source